WHO HEARTS: a global program to reduce cardiovascular disease burden: experience implementing in the Americas and opportunities in Canada

NRC Campbell, P Ordunez, G Giraldo… - Canadian Journal of …, 2021 - Elsevier
Globally, cardiovascular diseases (CVDs) are the leading cause of death. Viewed as a
threat to the global economy, the United Nations included reducing noncommunicable …

[HTML][HTML] Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study

R Martinez, P Lloyd-Sherlock, P Soliz… - The Lancet Global …, 2020 - thelancet.com
Background The reduction by a third of premature non-communicable disease (NCD)
mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4 …

[HTML][HTML] Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes

SJ Pickersgill, WT Msemburi, L Cobb, N Ide… - Nature medicine, 2022 - nature.com
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major
challenges for health systems. In this study, we analyzed the effects of better population …

The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: A population trend analysis of …

R Martinez, P Soliz, OJ Mujica, L Reveiz… - The Journal of …, 2020 - Wiley Online Library
Cardiovascular diseases (CVD) are leading causes of mortality and morbidity in the
Americas, resulting in substantial negative economic and social impacts. This study …

[HTML][HTML] HEARTS in the Americas: targeting health system change to improve population hypertension control

P Ordunez, NRC Campbell, DJ DiPette… - Current Hypertension …, 2024 - Springer
Purpose of Review HEARTS in the Americas is the regional adaptation of Global Hearts, the
World Health Organization initiative for cardiovascular disease (CVD) prevention and …

[HTML][HTML] Life expectancy, healthy life expectancy, and burden of disease in older people in the Americas, 1990–2019: a population-based study

R Martinez, P Morsch, P Soliz, C Hommes… - … de Salud Pública, 2021 - ncbi.nlm.nih.gov
Objective. To describe the life expectancy, healthy life expectancy, disease burden, and
leading causes of mortality and disability in adults aged 65 years and older in the Region of …

Mapping stages, barriers and facilitators to the implementation of HEARTS in the Americas initiative in 12 countries: a qualitative study

GP Giraldo, KT Joseph, SY Angell… - The Journal of …, 2021 - Wiley Online Library
Abstract The World Health Organization (WHO) Global Hearts Initiative offers technical
packages to reduce the burden of cardiovascular diseases through population‐wide and …

[HTML][HTML] Disparities in cardiovascular research output and disease outcomes among high-, middle-and low-income countries–an analysis of global cardiovascular …

NQ Qureshi, SH Mufarrih, GS Bloomfield, W Tariq… - Global Heart, 2021 - ncbi.nlm.nih.gov
Background: Cardiovascular disease (CVD) is the leading cause of death and disability
worldwide. Health research is crucial to managing disease burden. Previous work has …

Laser fabrication of composite layers from biopolymers with branched 3D networks of single-walled carbon nanotubes for cardiovascular implants

AY Gerasimenko, UE Kurilova, MS Savelyev… - Composite …, 2021 - Elsevier
A laser technology has been developed for fabricating structures from composite layers
based on biopolymers: albumin, collagen, and chitosan with single-walled carbon …

[HTML][HTML] Association of baseline as well as change in lipid levels with the risk of cardiovascular diseases and all-cause deaths

HY Hsu, MC Tsai, TL Yeh, LY Hsu, LC Hwang… - Scientific Reports, 2021 - nature.com
High baseline atherogenic lipid level has been an established risk factor for the risk of
cardiovascular events. Evidence concerning the role of lipid changes in cardiovascular and …